We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety and Tolerability of Transcranial Direct Current Stimulation (tDCS)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01148212
First Posted: June 22, 2010
Last Update Posted: February 8, 2011
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Ludwig-Maximilians - University of Munich
  Purpose

Testing safety and tolerability of transcranial direct current stimulation (2 mA, 20 minutes) in four different protocols:

saline-soaked sponges electrode with electrode gel tap-water-soaked sponges tap-water-soaked-sponges + sham stimulation

Outcome measures are tolerability (comfort rating questionnaire), impedances, skin elasticity


Condition
Best Comfort and Lowest Skin Irritation

Study Type: Observational
Study Design: Observational Model: Case-Only
Official Title: Safety and Tolerability of Transcranial Direct Current Stimulation (tDCS)

Further study details as provided by Ludwig-Maximilians - University of Munich:

Enrollment: 15
Study Start Date: June 2009
Study Completion Date: January 2011
Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 65 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
15 healthy volunteers
Criteria

Inclusion Criteria:

  • no neurological or psychiatric illness
  • written informed consent

Exclusion Criteria:

  • dermatologic diseases
  • medication with corticoids
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01148212


Locations
Germany
Ludwig-Maximilian-University, Dept. of Psychiatry
Munich, Germany, 80336
Sponsors and Collaborators
Ludwig-Maximilians - University of Munich
Investigators
Principal Investigator: Ulrich Palm, MD Ludwig-Maximilian-University
Study Chair: Frank Padberg, MD Ludwig-Maximilian-University
  More Information

Responsible Party: Ulrich Palm, MD, Ludwig-Maximilian-University Munich
ClinicalTrials.gov Identifier: NCT01148212     History of Changes
Other Study ID Numbers: 10/2009
First Submitted: June 21, 2010
First Posted: June 22, 2010
Last Update Posted: February 8, 2011
Last Verified: January 2011